Patents Assigned to Pacesetter, Inc.
  • Publication number: 20230135859
    Abstract: Described herein are methods, devices, and systems that monitor heart rate and/or for arrhythmic episodes based on sensed intervals that can include true R-R intervals as well as over-sensed R-R intervals. True R-R intervals are initially identified from an ordered list of the sensed intervals by comparing individual sensed intervals to a sum of an immediately preceding two intervals, and/or an immediately following two intervals. True R-R intervals are also identified by comparing sensed intervals to a mean or median of durations of sensed intervals already identified as true R-R intervals. Individual intervals in a remaining ordered list of sensed intervals (from which true R-R intervals have been removed) are classified as either a short interval or a long interval, and over-sensed R-R intervals are identified based on the results thereof. Such embodiments can be used, e.g., to reduce the reporting of and/or inappropriate responses to false positive tachycardia detections.
    Type: Application
    Filed: December 27, 2022
    Publication date: May 4, 2023
    Applicant: Pacesetter, Inc.
    Inventors: Nima Badie, Fujian Qu, Jong Gill
  • Patent number: 11633610
    Abstract: Implantable medical devices (IMDs) described herein, and methods for use therewith described herein, reduce how often an IMD accepts a false message and/or reduce adverse effects of an IMD accepting a false message. Such IMDs can be leadless pacemakers (LPs), or implantable cardio defibrillators (ICDs), but are not limited thereto. Such embodiments can be used help multiple IMDs (e.g., multiple LPs) implanted within a same patient maintain synchronous operation, such as synchronous multi-chamber pacing.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: April 25, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Donald Chin, Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Patent number: 11633609
    Abstract: A method is provided for establishing a communication session with an implantable medical device (“IMD”). The method includes configuring an IMD and an external device to communicate with one another through a protocol that utilizes a dedicated advertisement channel. The advertisement period and the scan period of the protocol are independent of one another such that the advertisement and scan periods at least partially overlap intermittently after a number of cycles. When the external device detects one of the advertisement notices, the method includes establishing a communications link between the external device and the IMD.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: April 25, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Reza Shahandeh, Richard Williamson, Gabriel Mouchawar, Brent Croft, William Winstrom, Robert McCormick, Jorge N. Amely-Velez, Thanh Tieu, Ali Dianaty, Samir Shah, Yongjian Wu
  • Patent number: 11636985
    Abstract: A cathode subassembly for use in an electrolytic capacitor may include a first separator sheet including a surface having first and second regions, where the second region extends from a perimeter of the first region to a first peripheral edge of the first sheet, a second peripheral edge of a second sheet is substantially aligned with the first peripheral edge, a conductive foil is sandwiched between the first and second sheets and disposed within the first region, the first and second sheets are adhered to each other in a sealing region extending from the second region to a region of a surface of the second sheet facing the second region, and the first sheet includes at least one first recess portion at the first peripheral edge aligned with at least one second recess portion at the second peripheral edge of the second sheet.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: April 25, 2023
    Assignee: Pacesetter, Inc.
    Inventors: David R. Bowen, Ralph Jason Hemphill, Thomas F. Strange, Troy L. McCurry, Peter Fernstrom
  • Patent number: 11633141
    Abstract: Computer implemented methods and systems for detecting arrhythmias in cardiac activity are provided. The method is under control of one or more processors configured with specific executable instructions. The method obtains a far field cardiac activity (CA) data set that includes far field CA signals for beats. The method applies a feature enhancement function to the CA signals to form an enhanced feature in the CA data set. The method calculates an adaptive sensitivity level and sensitivity limit based on the enhanced feature from one or more beats within the CA data set and automatically iteratively analyzes a beat segment of interest by comparing the beat segment of interest to the current sensitivity level to determine whether one or more R-waves are present within the beat segment of interest.
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: April 25, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Fady Dawoud, Fujian Qu, Stuart Rosenberg, Gene A. Bornzin, Jong Gill, Neha Malhotra, Xiaoyi Min
  • Publication number: 20230121674
    Abstract: Described herein are implantable medical devices and systems, and methods for use therewith, for reducing T-wave oversensing and arrythmia undersensing that occur due to inappropriate filtering of a signal indicative of cardiac electrical activity. A method includes obtaining a signal indicative of cardiac electrical activity, and using a first bandpass filter to produce a first filtered version thereof, using a second bandpass filter to produce a second filtered version thereof, wherein the first bandpass filter passes frequencies within a first frequency range, and the second bandpass filter passes frequencies within a second frequency range that is wider than the first frequency range. The method also includes selectively changing from using the first filtered version of the signal to monitor for a VS event, to using the second filtered version of the signal to monitor for a VS event, based on first criteria, and vice versa, based on second criteria.
    Type: Application
    Filed: May 13, 2022
    Publication date: April 20, 2023
    Applicant: Pacesetter, Inc.
    Inventors: Yun Qiao, Nima Badie, Wenwen Li, Chaoyi Kang, Jan Mangual, Fady Dawoud
  • Patent number: 11622325
    Abstract: A method for managing power during communication with an implantable medical device, including establishing a communications link, utilizing a power corresponding to a session start power, to initiate a current session between an implantable medical device (IMD) and external device. A telemetry break condition of the communications link is monitored during the current session. The power utilized by the IMD is adjusted between low and high power levels, during the current session based on the telemetry break condition. The number of sessions is counted, including the current session and one or more prior sessions, in which the IMD utilized the higher power level, and a level for the session start power to be utilized to initiate a next session following the current session is adaptively learned based on the counting of the number of sessions.
    Type: Grant
    Filed: February 22, 2022
    Date of Patent: April 4, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Perry Li, Lequan Zhang, Xing Pei, Jeffery Crook, Yongjian Wu, Jun Yang, Chao-Wen Young
  • Patent number: 11607540
    Abstract: A medical tool includes a rotation mechanism that further includes a warning feature. The warning feature provides an indication when the rotation mechanism has achieved a number of rotations.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: March 21, 2023
    Assignee: PACESETTER, INC.
    Inventors: Bradley Knippel, Daniel Coyle, Jennifer Heisel, Bernhard Arnar, Brett Hillukka, Tracee Eidenschink, Thomas B. Eby, Paul Paspa, Joseph Ramon Callol
  • Publication number: 20230072043
    Abstract: Described herein are methods, devices, and systems that identify ventricular sensed (VS) events from a signal indicative of cardiac electrical activity, such a far-field EGM or ECG signal, and monitor for an arrythmia and/or perform arrythmia discrimination based on the VS events. Beneficially, such embodiments reduce the probability of double-counting of R-wave, or more generally, of oversensing VS events, and thereby provide for improved arrythmia detection and arrythmia discrimination.
    Type: Application
    Filed: May 16, 2022
    Publication date: March 9, 2023
    Applicant: Pacesetter, Inc.
    Inventors: Yun Qiao, Nima Badie, Wenwen Li, Chaoyi Kang, Jan Mangual, Fady Dawoud
  • Patent number: 11596796
    Abstract: A computer implemented method and system is provided for managing neural stimulation therapy. The method comprises under control of one or more processors configured with program instructions. The method delivers a series of candidate stimulation waveforms having varied stimulation intensities to at least one electrode located proximate to nervous tissue of interest. A parameter defines the candidate stimulation waveforms is changed to vary the stimulation intensity. The method identifies a first candidate stimulation waveform that induces a paresthesia-abatement effect, while continuing to induce a select analgesic effect. The method further identifies a second candidate stimulation waveform that does not induce the select analgesic effect. The method sets a stimulation therapy based on the first and second candidate stimulation waveforms.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: March 7, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Alexander Kent, Richard Williamson
  • Publication number: 20230067795
    Abstract: Described herein are methods, devices and systems for efficiently storing data for sensed biological signals. A sensed biological signal, or an amplitude and/or filtered version thereof, is provided to an N-bit ADC of an IMD to produce an N-bit data value indicative of an amplitude of the biological signal at a point in time. One of a plurality of chords of a compression curve is selected, based on a magnitude of the N-bit data value, and used to produce an M-bit data value, which is a compressed version of the N-bit data value, wherein M<N. The M-bit data value is stored as an M-bit data slice within memory of the IMD, and can be expanded to a reproduced N-bit data value after being uploaded to a non-implanted device or system.
    Type: Application
    Filed: July 6, 2022
    Publication date: March 2, 2023
    Applicant: Pacesetter, Inc.
    Inventors: Dean Andersen, Xing Pei, David Doudna, Reza Shahandeh
  • Patent number: 11586229
    Abstract: A resistance weld shielding control system includes a computer that is executed to control a fixture to receive and hold at least one part to be welded. The computer also controls one or more electrodes to apply electrical energy to the part for welding the at least one part, and controls a gas delivery system to direct an inert gas onto the part for shielding the part from the ambient atmosphere via a nozzle. The nozzle is configured in the fixture such that the fixture holds the nozzle in a fixed physical relationship to the part.
    Type: Grant
    Filed: July 16, 2020
    Date of Patent: February 21, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Justin King, Russell Bruch, Nicholas R. Hamor, Kurt Erickson
  • Patent number: 11577086
    Abstract: A leafless biostimulator, such as a leadless pacemaker, includes a housing sized and configured to be implanted within a heart of a patient and includes both primary and secondary fixation features. The primary fixation feature is adapted to rotate to fix the leadless biostimulator to a wall of the heart during initial implantation. Once the leadless biostimulator is implanted, the secondary fixation feature is adapted to resist counter-rotation of the leadless biostimulator. The primary fixation feature may include a fixation helix configured to affix the housing to the heart by rotating in a screwing direction. The secondary fixation feature may include an apex to engage the heart to resist unscrewing of the primary fixation feature.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: February 14, 2023
    Assignee: PACESETTER, INC.
    Inventors: Thomas B. Eby, Christopher R. Jenney, Craig E. Mar, Paul M. Paspa
  • Patent number: 11577084
    Abstract: An implantable medical device (IMD) and method are provided. The IMD includes a sensing channel configured to obtain biological signals indicative of biological behavior of an anatomy of interest over a period of time. The biological behavior has a feature of interest that repeats over time. The biological signals have clinically relevant (CR) segments that include information related to the feature of interest. The biological signals have non-clinically relevant (NCR) segments that do not include information related to the feature of interest. At least one of circuitry or a processor are configured to compare the biological signals to an amplitude window to distinguish the CR segments from the NCR segments, save to memory the CR segments and delete the NCR segments, save to memory time information indicative of a duration of the NCR segments that were deleted and to form a lossy compressed data set for the biological signals.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: February 14, 2023
    Assignee: Pacesetter, Inc.
    Inventor: Dean P. Andersen
  • Patent number: 11571581
    Abstract: A leadless biostimulator, such as a leadless cardiac pacemaker, having a header assembly is described. The header assembly includes a helix mount mounted on a flange. An inner surface of the helix mount conforms to an outer surface of the flange, and the outer surface has a non-circular profile such that the conforming surfaces interfere with rotation of the helix mount relative to the flange. The non-circular profile includes a linear segment, such as a radial segment, that resists rotational movement of the helix mount. The helix mount has a protrusion that extends into a recess of the flange to interfere with longitudinal movement between the helix mount and the flange. The protrusion is formed before or after mounting the helix mount on the flange. The interfering surfaces threadlessly interconnect the header assembly components. Other embodiments are also described and claimed.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: February 7, 2023
    Assignee: PACESETTER, INC.
    Inventors: Joseph Hansen, Keith Victorine, Wesley Alleman
  • Patent number: 11564632
    Abstract: Computer implemented methods and systems for detecting noise in cardiac activity are provided. The method and system obtain a far field cardiac activity (CA) data set that includes far field CA signals for a series of beats, overlay a segment of the CA signals with a noise search window, and identify turns in the segment of the CA signals. The method and system determine whether the turns exhibit a turn characteristic that exceed a turn characteristic threshold, declare the segment of the CA signals as a noise segment based on the determining operation, shift the noise search window to a next segment of the CA signal and repeat the identifying, determining and declaring operations; and modify the CA signals based on the declaring the noise segments.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: January 31, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Jong Gill, Fujian Qu, Neha Malhotra, Stuart Rosenberg, Gene A. Bornzin, Fady Dawoud
  • Patent number: 11565119
    Abstract: A biostimulator, such as a leadless cardiac pacemaker, including a fixation element that can be locked to a helix mount, is described. The fixation element includes a fastener that engages a keeper of the helix mount. When engaged with the keeper, the fastener locks the fixation element to the helix mount. Accordingly, the fixation element does not move relative to the helix mount when the biostimulator is delivered into a target tissue. Other embodiments are also described and claimed.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: January 31, 2023
    Assignee: PACESETTER, INC.
    Inventor: Craig E. Mar
  • Patent number: 11564278
    Abstract: Systems and methods for managing bi-directional communication between an external device (ED) and an implantable medical device (IMD) are provided. The method comprises receiving an active ED configuration and a request for communications parameters to be used with the active ED configuration. The method further comprises identifying a pre-existing configuration, from a collection of pre-existing configurations that match the active ED configuration, the collection of pre-existing configurations having an associated collection of predefined parameter sets. The method further determines a resultant parameter set from the collection of predefined parameter sets based on the pre-existing configuration identified and returns the resultant parameter set in connection with the request, the resultant parameter set to be utilized by the ED for bi-directional communication with the IMD.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: January 24, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Taral Oza, Gabriel A. Mouchawar, Samir Shah, Tejpal Singh, John Stockton
  • Patent number: 11559241
    Abstract: Computer implemented methods and systems are provided that comprise, under control of one or more processors of a medical device, where the one or more processors are configured with specific executable instructions. The methods and systems obtain motion data indicative of at least one of a posture or a respiration cycle; obtain cardiac activity (CA) signals for a series of beats; identify whether a characteristic of interest (COI) from at least a first segment of the CA signals exceeds a COI limit; analyze the motion data to determine whether at least one of the posture or respiration cycle at least in part caused the COI to exceed the COI limit. Based on the analyzing operation, the methods and systems automatically adjust a CA sensing parameter utilized by the medical device to detect R-waves in subsequent CA signals; and detect an arrhythmia based on a presence or absence of one or more of the R-waves in at least a second segment of the CA signals.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: January 24, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Donald Hopper, Luke C. McSpadden, Fujian Qu, Gene Bornzin, Sinny Delacroix
  • Patent number: 11559242
    Abstract: Described herein are methods, devices, and systems that monitor heart rate and/or for arrhythmic episodes based on sensed intervals that can include true R-R intervals as well as over-sensed R-R intervals. True R-R intervals are initially identified from an ordered list of the sensed intervals by comparing individual sensed intervals to a sum of an immediately preceding two intervals, and/or an immediately following two intervals. True R-R intervals are also identified by comparing sensed intervals to a mean or median of durations of sensed intervals already identified as true R-R intervals. Individual intervals in a remaining ordered list of sensed intervals (from which true R-R intervals have been removed) are classified as either a short interval or a long interval, and over-sensed R-R intervals are identified based on the results thereof. Such embodiments can be used, e.g., to reduce the reporting of and/or inappropriate responses to false positive tachycardia detections.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: January 24, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Nima Badie, Fujian Qu, Jong Gill